Home / Import refusals / SCS-4494926-3/11/4

FDA Import Refusal SCS-4494926-3/11/4 — Cipla Limited

Cipla Limited — FEI 3004081307

The FDA refused shipment SCS-4494926-3/11/4 from Cipla Limited (India) on April 8, 2021. The refused product falls under Drugs and Biologics — ANTI-INFLAMMATORY N.E.C.. Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
April 8, 2021
Country
India
Product Category
Drugs and Biologics
Product Code
62GCA99 ANTI-INFLAMMATORY N.E.C.
Charges
75

Recent inspections

  • 1240813 (VAI Fri Jun 21 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1178952 (OAI Fri Aug 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1103305 (OAI Fri Sep 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1078911 (VAI Mon Jan 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1069950 (VAI Fri Sep 28 2018 00:00:00 GMT+0000 (Coordinated Universal Time))

Compliance actions

Other import refusals

  • 1FX-3441591-9/20002/4 (Fri Jul 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-1905741-3/20002/4 (Fri Jun 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-1905741-3/20002/5 (Fri Jun 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-4688178-4/10002/1 (Tue Jun 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-9797841-4/20002/1 (Tue Jun 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources